NYXH Nyxoah SA

1.420USD-0.70%Mkt Cap: 144.61M $P/E: —

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for …

Key Statistics

Company
Market Cap144.61M USD
Enterprise Value105.31M USD
Revenue (TTM)21.66M USD
Gross Profit6.33M USD
Net Income (TTM)-90.08M USD
Revenue/Share0.49 USD
Last Price1.420 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees153
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.73
PEG—
EV/EBITDA-1.27
EV/Revenue4.86
P/S6.72
P/B1.53
EPS (TTM)-2.56
EPS (Forward)-0.83
52W Range
1.2603% of range6.875
52W High6.875 USD
52W Low1.260 USD
Profitability
Gross Margin63.13%
Oper. Margin-268.25%
EBITDA Margin0.00%
Profit Margin-899.05%
ROE-183.36%
ROA-76.04%
Growth
Revenue Growth472.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-68.98M USD
CapEx (TTM)3.77M USD
FCF Margin-212.62%
FCF Yield-31.85%
Net Debt-37.80M USD
Net Debt/EBITDA0.46
Balance Sheet
Debt/Equity0.82
Current Ratio2.38
Quick Ratio2.28
Book Value/Sh0.93 USD
Cash/Share0.98 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.215 USD
Upside (mean)+196.8%
Target Range2.929 USD – 5.809 USD
2.929+196.8% to mean5.809
# Analysts3
Ownership
Shares Out.101.84M
Float50.88M
Insiders33.19%
Institutions30.87%
Short Interest
Short Ratio0.5d
Short % Float0.30%
Short % Out.0.26%
Shares Short269.14K
Short (prev mo.)474.70K
Technical
SMA 501.506 (-5.7%)
SMA 2002.853 (-50.2%)
Beta1.00
S&P 52W Chg15.78%
Avg Vol (30d)364.14K
Avg Vol (10d)240.51K
Technical Indicators
RSI (14)47.2
MACD-0.0422
MACD Signal-0.0437
MACD Hist.+0.0016
BB Upper1.635 USD
BB Middle1.448 USD
BB Lower1.261 USD
BB Width25.78%
ATR (14)0.0932 USD
Vol Ratio (20d)0.33x